Veery Capital LLC Takes $324,000 Position in Semler Scientific, Inc. (NASDAQ:SMLR)

Veery Capital LLC bought a new position in Semler Scientific, Inc. (NASDAQ:SMLR) in the fourth quarter, according to its most recent filing with the SEC. The firm bought 6,000 shares of the company’s stock, valued at approximately $324,000. Veery Capital LLC owned approximately 0.06% of Semler Scientific as of its most recent SEC filing.

Several other large investors also recently bought and sold shares of the stock. Bank of New York Mellon Corp grew its holdings in shares of Semler Scientific by 10.4% during the second quarter. Bank of New York Mellon Corp now owns 20,618 shares of the company’s stock valued at $709,000 after buying an additional 1,940 shares during the last quarter. Rhumbline Advisers lifted its position in Semler Scientific by 27.1% during the 2nd quarter. Rhumbline Advisers now owns 6,197 shares of the company’s stock worth $213,000 after acquiring an additional 1,320 shares during the period. Dimensional Fund Advisors LP grew its stake in Semler Scientific by 18.3% during the 2nd quarter. Dimensional Fund Advisors LP now owns 126,177 shares of the company’s stock valued at $4,341,000 after purchasing an additional 19,552 shares during the last quarter. AQR Capital Management LLC increased its holdings in shares of Semler Scientific by 150.1% in the second quarter. AQR Capital Management LLC now owns 140,498 shares of the company’s stock valued at $4,833,000 after purchasing an additional 84,314 shares during the period. Finally, Newbridge Financial Services Group Inc. purchased a new position in shares of Semler Scientific in the second quarter worth about $34,000. Hedge funds and other institutional investors own 49.37% of the company’s stock.

Semler Scientific Stock Up 11.1 %

Semler Scientific stock opened at $64.68 on Friday. Semler Scientific, Inc. has a 52 week low of $20.88 and a 52 week high of $81.56. The stock has a 50-day moving average price of $59.12 and a 200 day moving average price of $39.32. The company has a market capitalization of $599.58 million, a price-to-earnings ratio of 31.55 and a beta of 1.18.

Semler Scientific (NASDAQ:SMLR) last announced its quarterly earnings data on Monday, November 4th. The company reported $0.72 EPS for the quarter, beating the consensus estimate of $0.37 by $0.35. The business had revenue of $13.51 million during the quarter. Semler Scientific had a net margin of 27.00% and a return on equity of 20.31%.

Semler Scientific Company Profile

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.